Health Canada Has Suspended Market Authorization Of Adderall Xr™ (amphetamine Salts), A Drug Approved For Attention Deficit Hyperactivity Disorder (adhd) In Children

Reason

New safety information

Category

drug recall

Country

Canada

Agency

HC-DRUGS

Recall date

2005-02-11

Status

Closed

Distribution

Canada-wide

Official recall notice from HC-DRUGS

Recall details on Nibble Recalls: https://trynibble.app/recalls/9e3e7ba0-7632-4964-bca5-b3ff9421e83d